Evidence map›Paper›PMID 40572602›Full record

ArticleMolecules (Basel, Switzerland)2025

Synthesis of 1-(2-Hydroxy-5-methylphenyl)-5-oxopyrrolidine-3-carboxylic Acid Derivatives as a Promising Scaffold Against Disease-Causing Bacteria Relevant to Public Health.

Karolis Krikštaponis, Jūratė Šiugždaitė, Rita Vaickelionienė, Vytautas Mickevičius, Birutė Grybaitė

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karolis KrikštaponisDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.
Jūratė ŠiugždaitėDepartment of Veterinary Pathobiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania.ORCID 0009-0004-7523-2698
Rita VaickelionienėDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.
Vytautas MickevičiusDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.ORCID 0000-0002-9961-2941
Birutė GrybaitėDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.ORCID 0000-0003-0982-1342

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing number of antibiotic-resistant pathogens forces us to accelerate the search for new antimicrobial agents. Based on this, we chose to synthesize a library of 1-(2-hydroxy-5-methylphenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives and evaluate their antibacterial activity against various pathogens. A series of (2-hydroxy-5-methylphenyl)-5-oxopyrrolidine-3-carboxylic acid and its hydrazide derivatives were prepared and identified by the methods of IR,

Indexed as

Anti-Bacterial AgentsBacteriaCarboxylic AcidsPyrrolidinesBacillus cereusEscherichia coliListeria monocytogenesMicrobial Sensitivity TestsMolecular StructureStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsCarboxylic AcidsPyrrolidines5-oxopyrrolidineantibacterial activitybiofilm formationheterocycleshydrazone

Identifiers

PMID40572602
PMCPMC12196313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.